Samsara BioCapital’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Sell |
52,456
-2
| -0% | -$12 | 0.06% | 27 |
|
|
2025
Q1 | $420K | Hold |
52,458
| – | – | 0.07% | 31 |
|
|
2024
Q4 | $561K | Hold |
52,458
| – | – | 0.08% | 37 |
|
|
2024
Q3 | $680K | Hold |
52,458
| – | – | 0.13% | 36 |
|
|
2024
Q2 | $787K | Hold |
52,458
| – | – | 0.16% | 32 |
|
|
2024
Q1 | $1.47M | Hold |
52,458
| – | – | 0.23% | 31 |
|
|
2023
Q4 | $1.18M | Hold |
52,458
| – | – | 0.18% | 32 |
|
|
2023
Q3 | $1.09M | Hold |
52,458
| – | – | 0.33% | 31 |
|
|
2023
Q2 | $1.34M | Hold |
52,458
| – | – | 0.24% | 34 |
|
|
2023
Q1 | $1.46M | Hold |
52,458
| – | – | 0.3% | 36 |
|
|
2022
Q4 | $1.36M | Hold |
52,458
| – | – | 0.29% | 36 |
|
|
2022
Q3 | $1.55M | Hold |
52,458
| – | – | 0.36% | 39 |
|
|
2022
Q2 | $2.14M | Hold |
52,458
| – | – | 0.57% | 32 |
|
|
2022
Q1 | $2.88M | Buy |
52,458
+15,585
| +42% | +$854K | 0.72% | 33 |
|
|
2021
Q4 | $3.61M | Hold |
36,873
| – | – | 0.7% | 27 |
|
|
2021
Q3 | $9.33M | Hold |
36,873
| – | – | 1.46% | 15 |
|
|
2021
Q2 | $11.4M | Hold |
36,873
| – | – | 1.41% | 17 |
|
|
2021
Q1 | $24.3M | Buy |
+36,873
| New | +$24.3M | 4.48% | 7 |
|